Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1986 Mar;87(Suppl):1P–229P.

Proceedings of the British Pharmacological Society. 18th-20th December 1985. Abstracts.

PMCID: PMC1916640  PMID: 3955310

Full text

PDF
1P

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARUNLAKSHANA O., SCHILD H. O. Some quantitative uses of drug antagonists. Br J Pharmacol Chemother. 1959 Mar;14(1):48–58. doi: 10.1111/j.1476-5381.1959.tb00928.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Agre P., Virshup D., Bennett V. Bepridil and cetiedil. Vasodilators which inhibit Ca2+-dependent calmodulin interactions with erythrocyte membranes. J Clin Invest. 1984 Sep;74(3):812–820. doi: 10.1172/JCI111497. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Albano J., Bhoola K. D., Heap P. F., Lemon M. J. Stimulus-secretion coupling: role of cyclic AMP, cyclic GMP and calcium in mediating enzyme (kallikrein) secretion in the submandibular gland. J Physiol. 1976 Jul;258(3):631–658. doi: 10.1113/jphysiol.1976.sp011438. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Ashley R. H., Brammer M. J., Marchbanks R. Measurement of intrasynaptosomal free calcium by using the fluorescent indicator quin-2. Biochem J. 1984 Apr 1;219(1):149–158. doi: 10.1042/bj2190149. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Barlow R. B., Shepherd M. K. A search for selective antagonists at M2 muscarinic receptors. Br J Pharmacol. 1985 Jun;85(2):427–435. doi: 10.1111/j.1476-5381.1985.tb08878.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Barlow R. B., Weston-Smith P. The relative potencies of some agonists at M2 muscarinic receptors in guinea-pig ileum, atria and bronchi. Br J Pharmacol. 1985 Jun;85(2):437–440. doi: 10.1111/j.1476-5381.1985.tb08879.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Beck N. P., Kaneko T., Zor U., Field J. B., Davis B. B. Effects of vasopressin and prostaglandin E 1 on the adenyl cyclase-cyclic 3',5'-adenosine monophosphate system of the renal medulla of the rat. J Clin Invest. 1971 Dec;50(12):2461–2465. doi: 10.1172/JCI106746. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Braestrup C., Nielsen M. [3H]Propyl beta-carboline-3-carboxylate as a selective radioligand for the BZ1 benzodiazepine receptor subclass. J Neurochem. 1981 Aug;37(2):333–341. doi: 10.1111/j.1471-4159.1981.tb00460.x. [DOI] [PubMed] [Google Scholar]
  9. Brown E., Kendall D. A., Nahorski S. R. Inositol phospholipid hydrolysis in rat cerebral cortical slices: I. Receptor characterisation. J Neurochem. 1984 May;42(5):1379–1387. doi: 10.1111/j.1471-4159.1984.tb02798.x. [DOI] [PubMed] [Google Scholar]
  10. Cambridge D. UK-14,304, a potent and selective alpha2-agonist for the characterisation of alpha-adrenoceptor subtypes. Eur J Pharmacol. 1981 Jul 10;72(4):413–415. doi: 10.1016/0014-2999(81)90588-4. [DOI] [PubMed] [Google Scholar]
  11. Cantrill R., Arbilla S., Zivkovic B., Langer S. Z. Amphetamine enhances latent dopaminergic neurotransmission in the rat striatum. Effects on 3H-acetylcholine release. Naunyn Schmiedebergs Arch Pharmacol. 1983 May;322(4):322–324. doi: 10.1007/BF00508350. [DOI] [PubMed] [Google Scholar]
  12. Carbone E., Lux H. D. A low voltage-activated calcium conductance in embryonic chick sensory neurons. Biophys J. 1984 Sep;46(3):413–418. doi: 10.1016/S0006-3495(84)84037-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Cherubini E., North R. A. Inhibition of calcium spikes and transmitter release by gamma-aminobutyric acid in the guinea-pig myenteric plexus. Br J Pharmacol. 1984 May;82(1):101–105. doi: 10.1111/j.1476-5381.1984.tb16446.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Choo L. K., Leung E., Mitchelson F. Failure of gallamine and pancuronium to inhibit selectively (-)-[3H]quinuclidinyl benzilate binding in guinea-pig atria. Can J Physiol Pharmacol. 1985 Mar;63(3):200–208. doi: 10.1139/y85-038. [DOI] [PubMed] [Google Scholar]
  15. Clague R. U., Eglen R. M., Strachan A. C., Whiting R. L. Action of agonists and antagonists at muscarinic receptors present on ileum and atria in vitro. Br J Pharmacol. 1985 Sep;86(1):163–170. doi: 10.1111/j.1476-5381.1985.tb09446.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Clark A. L., Mitchelson F. The inhibitory effect of gallamine on muscarinic receptors. Br J Pharmacol. 1976 Nov;58(3):323–331. doi: 10.1111/j.1476-5381.1976.tb07708.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Classen K., Göthert M., Schlicker E. Effects of DU 24565 (6-nitroquipazine) on serotoninergic and noradrenergic neurones of the rat brain and comparison with the effects of quipazine. Naunyn Schmiedebergs Arch Pharmacol. 1984 Jun;326(3):198–202. doi: 10.1007/BF00505318. [DOI] [PubMed] [Google Scholar]
  18. Cohen M. L., Fuller R. W., Kurz K. D. LY53857, a selective and potent serotonergic (5-HT2) receptor antagonist, does not lower blood pressure in the spontaneously hypertensive rat. J Pharmacol Exp Ther. 1983 Nov;227(2):327–332. [PubMed] [Google Scholar]
  19. Csonka G. W., Tyrrell D. A. Treatment of herpes genitalis with carbenoxolone and cicloxolone creams: a double blind placebo controlled clinical trial. Br J Vener Dis. 1984 Jun;60(3):178–181. doi: 10.1136/sti.60.3.178. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Daniel E. E. Cellular calcium mobilization. J Cardiovasc Pharmacol. 1984;6 (Suppl 4):S622–S629. doi: 10.1097/00005344-198406004-00008. [DOI] [PubMed] [Google Scholar]
  21. Dourish C. T., Hutson P. H., Curzon G. Low doses of the putative serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) elicit feeding in the rat. Psychopharmacology (Berl) 1985;86(1-2):197–204. doi: 10.1007/BF00431709. [DOI] [PubMed] [Google Scholar]
  22. Dourish C. T., Hutson P. H., Curzon G. Low doses of the putative serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) elicit feeding in the rat. Psychopharmacology (Berl) 1985;86(1-2):197–204. doi: 10.1007/BF00431709. [DOI] [PubMed] [Google Scholar]
  23. Doyle V. M., Rüegg U. T. Vasopressin induced production of inositol trisphosphate and calcium efflux in a smooth muscle cell line. Biochem Biophys Res Commun. 1985 Aug 30;131(1):469–476. doi: 10.1016/0006-291x(85)91826-1. [DOI] [PubMed] [Google Scholar]
  24. Dupont A. G., Lefebvre R. A., Bogaert M. G. Inhibitory effects of apomorphine and pergolide on neurogenic vasoconstriction in the hindquarters of the rat. Naunyn Schmiedebergs Arch Pharmacol. 1985 Apr;329(2):146–151. doi: 10.1007/BF00501204. [DOI] [PubMed] [Google Scholar]
  25. Désarmenien M., Feltz P., Occhipinti G., Santangelo F., Schlichter R. Coexistence of GABAA and GABAB receptors on A delta and C primary afferents. Br J Pharmacol. 1984 Feb;81(2):327–333. doi: 10.1111/j.1476-5381.1984.tb10082.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Ehara T., Daufmann R. The voltage- and time-dependent effects of (-)-verapamil on the slow inward current in isolated cat ventricular myocardium. J Pharmacol Exp Ther. 1978 Oct;207(1):49–55. [PubMed] [Google Scholar]
  27. Fisher S. K., Klinger P. D., Agranoff B. W. Muscarinic agonist binding and phospholipid turnover in brain. J Biol Chem. 1983 Jun 25;258(12):7358–7363. [PubMed] [Google Scholar]
  28. Furchgott R. F., Zawadzki J. V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980 Nov 27;288(5789):373–376. doi: 10.1038/288373a0. [DOI] [PubMed] [Google Scholar]
  29. Gillis C. N., Pitt B. R. The fate of circulating amines within the pulmonary circulation. Annu Rev Physiol. 1982;44:269–281. doi: 10.1146/annurev.ph.44.030182.001413. [DOI] [PubMed] [Google Scholar]
  30. Gozlan H., El Mestikawy S., Pichat L., Glowinski J., Hamon M. Identification of presynaptic serotonin autoreceptors using a new ligand: 3H-PAT. Nature. 1983 Sep 8;305(5930):140–142. doi: 10.1038/305140a0. [DOI] [PubMed] [Google Scholar]
  31. Grohmann M., Trendelenburg U. The substrate specificity of uptake2 in the rat heart. Naunyn Schmiedebergs Arch Pharmacol. 1984 Dec;328(2):164–173. doi: 10.1007/BF00512067. [DOI] [PubMed] [Google Scholar]
  32. Hallam T. J., Sanchez A., Rink T. J. Stimulus-response coupling in human platelets. Changes evoked by platelet-activating factor in cytoplasmic free calcium monitored with the fluorescent calcium indicator quin2. Biochem J. 1984 Mar 15;218(3):819–827. doi: 10.1042/bj2180819. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Hamill O. P., Marty A., Neher E., Sakmann B., Sigworth F. J. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch. 1981 Aug;391(2):85–100. doi: 10.1007/BF00656997. [DOI] [PubMed] [Google Scholar]
  34. Hammer R., Berrie C. P., Birdsall N. J., Burgen A. S., Hulme E. C. Pirenzepine distinguishes between different subclasses of muscarinic receptors. Nature. 1980 Jan 3;283(5742):90–92. doi: 10.1038/283090a0. [DOI] [PubMed] [Google Scholar]
  35. Hammer R., Giachetti A. Muscarinic receptor subtypes: M1 and M2 biochemical and functional characterization. Life Sci. 1982 Dec 27;31(26):2991–2998. doi: 10.1016/0024-3205(82)90066-2. [DOI] [PubMed] [Google Scholar]
  36. Hoyer D., Engel G., Kalkman H. O. Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin. Eur J Pharmacol. 1985 Nov 26;118(1-2):13–23. doi: 10.1016/0014-2999(85)90658-2. [DOI] [PubMed] [Google Scholar]
  37. Hyttel J. SCH 23390 - the first selective dopamine D-1 antagonist. Eur J Pharmacol. 1983 Jul 15;91(1):153–154. doi: 10.1016/0014-2999(83)90381-3. [DOI] [PubMed] [Google Scholar]
  38. Iorio L. C., Barnett A., Leitz F. H., Houser V. P., Korduba C. A. SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems. J Pharmacol Exp Ther. 1983 Aug;226(2):462–468. [PubMed] [Google Scholar]
  39. Itoh H., Ishikawa T., Hidaka H. Effects on calmodulin of bepridil, an antianginal agent. J Pharmacol Exp Ther. 1984 Sep;230(3):737–741. [PubMed] [Google Scholar]
  40. Kamal L. A., Arbilla S., Langer S. Z. Presynaptic modulation of the release of dopamine from the rabbit caudate nucleus: differences between electrical stimulation, amphetamine and tyramine. J Pharmacol Exp Ther. 1981 Mar;216(3):592–598. [PubMed] [Google Scholar]
  41. Karnovsky M. J., Kleinfeld A. M., Hoover R. L., Dawidowicz E. A., McIntyre D. E., Salzman E. A., Klausner R. D. Lipid domains in membranes. Ann N Y Acad Sci. 1982;401:61–75. doi: 10.1111/j.1749-6632.1982.tb25707.x. [DOI] [PubMed] [Google Scholar]
  42. Kennett G. A., Dickinson S. L., Curzon G. Enhancement of some 5-HT-dependent behavioural responses following repeated immobilization in rats. Brain Res. 1985 Mar 25;330(2):253–263. doi: 10.1016/0006-8993(85)90684-5. [DOI] [PubMed] [Google Scholar]
  43. Kistler G. S., Caldwell P. R., Weibel E. R. Development of fine structural damage to alveolar and capillary lining cells in oxygen-poisoned rat lungs. J Cell Biol. 1967 Mar;32(3):605–628. doi: 10.1083/jcb.32.3.605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Langer S. Z., Moret C. Citalopram antagonizes the stimulation by lysergic acid diethylamide of presynaptic inhibitory serotonin autoreceptors in the rat hypothalamus. J Pharmacol Exp Ther. 1982 Jul;222(1):220–226. [PubMed] [Google Scholar]
  45. Leonard B. E. The olfactory bulbectomized rat as a model of depression. Pol J Pharmacol Pharm. 1984 Sep-Oct;36(5):561–569. [PubMed] [Google Scholar]
  46. Levine J. D., Lau W., Kwiat G., Goetzl E. J. Leukotriene B4 produces hyperalgesia that is dependent on polymorphonuclear leukocytes. Science. 1984 Aug 17;225(4663):743–745. doi: 10.1126/science.6087456. [DOI] [PubMed] [Google Scholar]
  47. Lewis D. A. Endogenous anti-inflammatory factors. Biochem Pharmacol. 1984 Jun 1;33(11):1705–1714. doi: 10.1016/0006-2952(84)90337-x. [DOI] [PubMed] [Google Scholar]
  48. Leysen J. E., Niemegeers C. J., Van Nueten J. M., Laduron P. M. [3H]Ketanserin (R 41 468), a selective 3H-ligand for serotonin2 receptor binding sites. Binding properties, brain distribution, and functional role. Mol Pharmacol. 1982 Mar;21(2):301–314. [PubMed] [Google Scholar]
  49. Lloyd K. G., Morselli P. L., Depoortere H., Fournier V., Zivkovic B., Scatton B., Broekkamp C., Worms P., Bartholini G. The potential use of GABA agonists in psychiatric disorders: evidence from studies with progabide in animal models and clinical trials. Pharmacol Biochem Behav. 1983 Jun;18(6):957–966. doi: 10.1016/s0091-3057(83)80021-5. [DOI] [PubMed] [Google Scholar]
  50. Lo M. M., Strittmatter S. M., Snyder S. H. Physical separation and characterization of two types of benzodiazepine receptors. Proc Natl Acad Sci U S A. 1982 Jan;79(2):680–684. doi: 10.1073/pnas.79.2.680. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Lokhandwala M. F., Steenberg M. L. Selective activation by LY-141865 and apomorphine of presynaptic dopamine receptors in the rat kidney and influence of stimulation parameters in the action of dopamine. J Pharmacol Exp Ther. 1984 Jan;228(1):161–167. [PubMed] [Google Scholar]
  52. Lugnier C., Follenius A., Gerard D., Stoclet J. C. Bepridil and flunarizine as calmodulin inhibitors. Eur J Pharmacol. 1984 Feb 10;98(1):157–158. doi: 10.1016/0014-2999(84)90128-6. [DOI] [PubMed] [Google Scholar]
  53. MacDermot J., Kelsey C. R., Waddell K. A., Richmond R., Knight R. K., Cole P. J., Dollery C. T., Landon D. N., Blair I. A. Synthesis of leukotriene B4, and prostanoids by human alveolar macrophages: analysis by gas chromatography/mass spectrometry. Prostaglandins. 1984 Feb;27(2):163–179. doi: 10.1016/0090-6980(84)90071-6. [DOI] [PubMed] [Google Scholar]
  54. MacIntyre D. E., Hoover R. L., Smith M., Steer M., Lynch C., Karnovsky M. J., Salzman E. W. Inhibition of platelet function by cis-unsaturated fatty acids. Blood. 1984 Apr;63(4):848–857. [PubMed] [Google Scholar]
  55. Marchi M., Raiteri M. Differential antagonism by dicyclomine, pirenzepine and secoverine at muscarinic receptor subtypes in the rat frontal cortex. Eur J Pharmacol. 1985 Jan 2;107(2):287–288. doi: 10.1016/0014-2999(85)90074-3. [DOI] [PubMed] [Google Scholar]
  56. Miller R. J., Freedman S. B. Are dihydropyridine binding sites voltage sensitive calcium channels? Life Sci. 1984 Mar 26;34(13):1205–1221. doi: 10.1016/0024-3205(84)90543-5. [DOI] [PubMed] [Google Scholar]
  57. Nishizuka Y. The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature. 1984 Apr 19;308(5961):693–698. doi: 10.1038/308693a0. [DOI] [PubMed] [Google Scholar]
  58. O'Boyle K. M., Waddington J. L. Selective and stereospecific interactions of R-SK & F 38393 with [3H]piflutixol but not [3H]spiperone binding to striatal D1 and D2 dopamine receptors: comparisons with SCH 23390. Eur J Pharmacol. 1984 Mar 2;98(3-4):433–436. doi: 10.1016/0014-2999(84)90294-2. [DOI] [PubMed] [Google Scholar]
  59. Parnham M. J., Kindt S. A novel biologically active seleno-organic compound--III. Effects of PZ 51 (Ebselen) on glutathione peroxidase and secretory activities of mouse macrophages. Biochem Pharmacol. 1984 Oct 15;33(20):3247–3250. doi: 10.1016/0006-2952(84)90085-6. [DOI] [PubMed] [Google Scholar]
  60. Passeri M., Cucinotta D., de Mello M., Storchi G., Roncucci R., Bizière K. Minaprine for senile dementia. Lancet. 1985 Apr 6;1(8432):824–824. doi: 10.1016/s0140-6736(85)91488-6. [DOI] [PubMed] [Google Scholar]
  61. Pazos A., Hoyer D., Palacios J. M. The binding of serotonergic ligands to the porcine choroid plexus: characterization of a new type of serotonin recognition site. Eur J Pharmacol. 1984 Nov 27;106(3):539–546. doi: 10.1016/0014-2999(84)90057-8. [DOI] [PubMed] [Google Scholar]
  62. Pedigo N. W., Yamamura H. I., Nelson D. L. Discrimination of multiple [3H]5-hydroxytryptamine binding sites by the neuroleptic spiperone in rat brain. J Neurochem. 1981 Jan;36(1):220–226. doi: 10.1111/j.1471-4159.1981.tb02397.x. [DOI] [PubMed] [Google Scholar]
  63. Pedigo N. W., Yamamura H. I., Nelson D. L. Discrimination of multiple [3H]5-hydroxytryptamine binding sites by the neuroleptic spiperone in rat brain. J Neurochem. 1981 Jan;36(1):220–226. doi: 10.1111/j.1471-4159.1981.tb02397.x. [DOI] [PubMed] [Google Scholar]
  64. Peroutka S. J., Snyder S. H. Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol. Mol Pharmacol. 1979 Nov;16(3):687–699. [PubMed] [Google Scholar]
  65. Peroutka S. J., Snyder S. H. Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol. Mol Pharmacol. 1979 Nov;16(3):687–699. [PubMed] [Google Scholar]
  66. Pilc A., Lloyd K. G. Chronic antidepressants and GABA "B" receptors: a GABA hypothesis of antidepressant drug action. Life Sci. 1984 Nov 19;35(21):2149–2154. doi: 10.1016/0024-3205(84)90515-0. [DOI] [PubMed] [Google Scholar]
  67. Pollock W. K., Armstrong R. A., Brydon L. J., Jones R. L., MacIntyre D. E. Thromboxane-induced phosphatidate formation in human platelets. Relationship to receptor occupancy and to changes in cytosolic free calcium. Biochem J. 1984 May 1;219(3):833–842. doi: 10.1042/bj2190833. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Poswillo D. E., Roberts G. J. Topical carbenoxolone for orofacial herpes simplex infections. Lancet. 1981 Jul 18;2(8238):143–144. doi: 10.1016/s0140-6736(81)90318-4. [DOI] [PubMed] [Google Scholar]
  69. Raiteri M., Bonanno G., Marchi M., Maura G. Is there a functional linkage between neurotransmitter uptake mechanisms and presynaptic receptors? J Pharmacol Exp Ther. 1984 Dec;231(3):671–677. [PubMed] [Google Scholar]
  70. Rasmussen H., Barrett P. Q. Calcium messenger system: an integrated view. Physiol Rev. 1984 Jul;64(3):938–984. doi: 10.1152/physrev.1984.64.3.938. [DOI] [PubMed] [Google Scholar]
  71. Robbins T. W., Roberts D. C., Koob G. F. Effects of d-amphetamine and apomorphine upon operant behavior and schedule-induced licking in rats with 6-hydroxydopamine-induced lesions of the nucleus accumbens. J Pharmacol Exp Ther. 1983 Mar;224(3):662–673. [PubMed] [Google Scholar]
  72. Safayhi H., Tiegs G., Wendel A. A novel biologically active seleno-organic compound--V. Inhibition by ebselen (PZ 51) of rat peritoneal neutrophil lipoxygenase. Biochem Pharmacol. 1985 Aug 1;34(15):2691–2694. doi: 10.1016/0006-2952(85)90569-6. [DOI] [PubMed] [Google Scholar]
  73. Sherman A. D., Petty F. Additivity of neurochemical changes in learned helplessness and imipramine. Behav Neural Biol. 1982 Aug;35(4):344–353. doi: 10.1016/s0163-1047(82)90978-5. [DOI] [PubMed] [Google Scholar]
  74. Sieghart W., Schuster A. Affinity of various ligands for benzodiazepine receptors in rat cerebellum and hippocampus. Biochem Pharmacol. 1984 Dec 15;33(24):4033–4038. doi: 10.1016/0006-2952(84)90017-0. [DOI] [PubMed] [Google Scholar]
  75. Siegl A. M., Daly J. W., Smith J. B. Inhibition of aggregation and stimulation of cyclic AMP generation in intact human platelets by the diterpene forskolin. Mol Pharmacol. 1982 May;21(3):680–687. [PubMed] [Google Scholar]
  76. Simmonds M. A. Distinction between the effects of barbiturates, benzodiazepines and phenytoin on responses to gamma-aminobutyric acid receptor activation and antagonism by bicuculline and picrotoxin. Br J Pharmacol. 1981 Jul;73(3):739–747. doi: 10.1111/j.1476-5381.1981.tb16810.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Stockton J. M., Birdsall N. J., Burgen A. S., Hulme E. C. Modification of the binding properties of muscarinic receptors by gallamine. Mol Pharmacol. 1983 May;23(3):551–557. [PubMed] [Google Scholar]
  78. Stoof J. C., Kebabian J. W. Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum. Nature. 1981 Nov 26;294(5839):366–368. doi: 10.1038/294366a0. [DOI] [PubMed] [Google Scholar]
  79. Tomioka M., Ida S., Shindoh Y., Ishihara T., Takishima T. Mast cells in bronchoalveolar lumen of patients with bronchial asthma. Am Rev Respir Dis. 1984 Jun;129(6):1000–1005. doi: 10.1164/arrd.1984.129.6.1000. [DOI] [PubMed] [Google Scholar]
  80. Tsien R. Y., Pozzan T., Rink T. J. Calcium homeostasis in intact lymphocytes: cytoplasmic free calcium monitored with a new, intracellularly trapped fluorescent indicator. J Cell Biol. 1982 Aug;94(2):325–334. doi: 10.1083/jcb.94.2.325. [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Van Breemen C., Farinas B. R., Gerba P., McNaughton E. D. Excitation-contraction coupling in rabbit aorta studied by the lanthanum method for measuring cellular calcium influx. Circ Res. 1972 Jan;30(1):44–54. doi: 10.1161/01.res.30.1.44. [DOI] [PubMed] [Google Scholar]
  82. Vogel C. W., Smith C. A., Müller-Eberhard H. J. Cobra venom factor: structural homology with the third component of human complement. J Immunol. 1984 Dec;133(6):3235–3241. [PubMed] [Google Scholar]
  83. Wang C. C., Pong S. S. Actions of avermectin B1a on GABA nerves. Prog Clin Biol Res. 1982;97:373–395. [PubMed] [Google Scholar]
  84. Watanabe Y., Khatami S., Shibuya T., Salafsky B. Ontogenetic properties of benzodiazepine receptor subtypes in rat spinal cord. Eur J Pharmacol. 1985 Feb 26;109(2):307–309. doi: 10.1016/0014-2999(85)90438-8. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES